title: Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
authors: F
authors: F
authors: Bach
authors: J
authors: J
authors: Vibe-Petersen
authors: J B
authors: JB
authors: Sørensen
authors: P
authors: P
authors: Dombernowsky
authors: H H
authors: HH
authors: Hansen
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D012074:Remission Induction; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D009607:Nitrosourea Compounds; D013654:Taurine; C052991:1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea; D014751:Vindesine